Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence
Background and aims Hepatocellular carcinoma (HCC) recurrence was previously characterized into four types, and patients with progression/hyper-progression recurrence (type III–IV) have an extremely poor prognosis. However, the immune background of resectable HCC, particularly in patients who experi...
Saved in:
Main Authors: | Jing-Xuan Xu, Yue-Xiang Su, Yuan-Yuan Chen, Yi-Yue Huang, Zu-Shun Chen, Yu-Chong Peng, Lu-Nan Qi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2456113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of research progress on disease burden of foodborne aflatoxins
by: Mei QIN, et al.
Published: (2024-12-01) -
Progress and Criticism of Progress as a Characteristic of Modern Civilizations in the Work of Friedrich Nietzsche and Ludwig Wittgenstein
by: Ulrich Arnswald
Published: (2024-10-01) -
Progression patterns in patients with advanced hepatocellular carcinoma treated with local therapy, targeted drugs, and PD-1/PD-L1 inhibitors
by: Yanan Zhao, et al.
Published: (2024-08-01) -
Mutual causal effects between immune cells and hepatocellular carcinoma: a Mendelian randomization study
by: Zheng Wang, et al.
Published: (2025-01-01) -
Genetic Determinants of Immune Cells and Hepatocellular Carcinoma Risk: A Bioinformatics and Bidirectional Mendelian Randomization Study
by: Tong WU, et al.
Published: (2025-01-01)